Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02697721 · ClinicalTrials.gov registry record · NA

Powerful Tools for Caregivers of Dementia Patients

A NA study of Alzheimer Disease and Dementia, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02697721 is a NA study of Alzheimer Disease and Dementia that has completed, run by Florida State University. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02697721, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine if a psycho-educational intervention for caregivers of patients with dementia will decrease caregiver burden, increase caregiver physical activity, and decrease the reporting of behavioral and psychological symptoms of the person with dementia.

Interventions

  • BEHAVIORAL Powerful Tools for Caregivers
  • OTHER Control with delayed intervention

Study Locations (1)

Florida

  • Florida State University College of Medicine - Tallahassee

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-02
Est. Completion 2019-02
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT02697721

The ClinicalTrials.gov registry entry for NCT02697721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Powerful Tools for Caregivers is the first listed.

NCT02697721 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02697721 about?

NCT02697721 is a clinical study titled "Powerful Tools for Caregivers of Dementia Patients". The purpose of this study is to examine if a psycho-educational intervention for caregivers of patients with dementia will decrease caregiver burden, increase caregiver physical activity, and decrease the reporting of behavioral and psychological symptoms of the person with dementia.

What is the current status of trial NCT02697721?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-02. Estimated completion is 2019-02.

What conditions does trial NCT02697721 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Caregivers.

What interventions are being tested in trial NCT02697721?

The interventions under investigation include: Powerful Tools for Caregivers (BEHAVIORAL), Control with delayed intervention (OTHER).

Who is sponsoring clinical trial NCT02697721?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02697721 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.